Making Medicare Advantage profitable again

We're certainly not the first people to notice that, for health insurers, Medicare Advantage has lost a bit of its luster. During Q4 and Q1 earnings season, an unmistakable correlation was obvious: the greater an insurer's exposure to MA, the worse its performance on medical loss ratio—with knock-on effects on its stock price. 

Christopher Kerns
Christopher Kerns
Updated Jul 19, 2024 4 min read

We’re certainly not the first people to notice that, for health insurers, Medicare Advantage has lost a bit of its luster. During Q4 and Q1 earnings season, an unmistakable correlation was obvious: the greater an insurer’s exposure to MA, the worse its performance on medical loss ratio—with knock-on effects on its stock price. The opposite was also true: the less the MA exposure, the better the overall MLR performance.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.